CommercialCoverageMedium impact
Suit Therapy (CPB 0696, reviewed 2025-11-26)
Aetna·Pediatrics, Physical Therapy, Occupational Therapy +3 more·Medical Policy
We identified it
Aug 17, 2026
Summary
Aetna's CPB 0696 policy classifies suit therapy devices (Adeli Suit, Dynamic Lycra Suit, Benik Dynamic Trunk Orthosis, and related elastomeric orthoses) as experimental and investigational for all indications including cerebral palsy, stroke rehabilitation, scoliosis, hemiparesis, and autism. These devices are NOT covered. Billing teams must deny all claims for suit therapy and related devices, and ensure providers understand the comprehensive documentation and Standard Written Order requirements that now apply to any orthotic device submissions.
Action Required
Immediately: (1) Billing team must update denial templates and billing software to automatically deny all claims for suit therapy devices under CPB 0696, including any claims coded as A4467 (Belt, strap, sleeve, garment, or covering) or L1200 (TLSO) when the clinical indication is for suit therapy, cerebral palsy, dynamic movement orthosis, Benik trunk orthosis, or related elastomeric devices. (2) Providers and suppliers must be notified that suit therapy devices are non-covered experimental interventions. (3) For all orthotic device claims going forward, enforce the Standard Written Order (SWO) requirement in billing software: claims cannot be submitted without documented evidence that supplier received a completed SWO containing member name/ID, order date, HCPCS code with quantity, all accessories/options listed separately with codes, treating practitioner name/NPI, and treating practitioner signature. (4) Update denial messages to reference the DME MAC policy requirement that supplier-prepared statements and physician attestations alone do NOT constitute sufficient medical necessity documentation—medical records must independently support the claim. (5) Flag any claims from suppliers or providers with financial interest in the outcome for manual review per DME MAC policy. Failure to implement these controls will result in claim denials and potential overpayment recovery.